Why the study?
Does preimplantation genetic diagnosis combined with IVF prevent the transmission of Marfan syndrome to offspring in an asymptomatic affected woman?
Does preimplantation genetic diagnosis combined with IVF prevent the transmission of Marfan syndrome to offspring in an asymptomatic affected woman?
Preimplantation genetic diagnosis combined with IVF can successfully prevent the transmission of Marfan syndrome to offspring while maintaining maternal safety in asymptomatic patients.
Answers are grounded in this paper and cite their sources.
Supports feasibility of PGD+IVF in asymptomatic Marfan syndrome; hypothesis-generating and should not yet change practice.
Marfan syndrome (MFS) is a systemic hereditable disorder of the connective tissue with mainly cardiovascular manifestations, such as aortic dilatation and dissection. We describe a case of a 32-year-old Caucasian woman, clinically asymptomatic with MFS who presented for genetic consultation to prevent the transmission of disease to her offspring. She underwent controlled ovarian stimulation (COH), in vitro fertilization (IVF) combined with preimplantation genetic diagnosis (PGD), and a singleton pregnancy with positive fetal heart rate was revealed. At 34 weeks' gestation she delivered vaginally a healthy premature male infant weighting 2440 gr. The patient remained asymptomatic during pregnancy, delivery, and 3 months postpartum. It is has to be mentioned that the availability of PGD is essential to prevent the transmission of disease to the next generation.
No takes yet. Share an insight, caveat, or question.
Vlahos et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: